CARA THERAPEUTICS INC. Archives

Home Tags CARA THERAPEUTICS INC.

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Other Events

ME Staff 8-k - March 25, 2020

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - January 14, 2020

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - December 16, 2019

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Entry into a Material...

ME Staff 8-k - August 21, 2019

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating...

ME Staff - February 6, 2019

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating

ME Staff - December 20, 2018

Cara Therapeutics Inc (NASDAQ:CARA) price target set to $27.00 by Cantor...

ME Staff - November 7, 2018

Cara Therapeutics Inc (NASDAQ:CARA) had its Buy rating reiterated by Cantor...

ME Staff - October 4, 2018

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating...

ME Staff - September 21, 2018

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating

ME Staff - September 13, 2018

12 Page 1 of 2

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 21, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: CARA THERAPEUTICS INC.

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Other Events

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Regulation FD Disclosure

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Regulation FD Disclosure

CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Entry into a Material...

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating...

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating

Cara Therapeutics Inc (NASDAQ:CARA) price target set to $27.00 by Cantor...

Cara Therapeutics Inc (NASDAQ:CARA) had its Buy rating reiterated by Cantor...

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating...

Cara Therapeutics Inc (NASDAQ:CARA) has coverage initiated with a Buy rating

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY